EFFECT OF SUBCUTANEOUS RECOMBINANT HUMAN ERYTHROPOIETIN ON BLOOD PRESSURE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) PATIENTS

Objective: To determine the effect of subcutaneous recombinant human erythropoietin on blood pressure in pre-dialysis chronic kidney disease (CKD) patients. Study Design: Case-series descriptive study. Place and Duration of Study: Combined Military Hospital Peshawar, from Mar 2016 to Sep 2016. Metho...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Muhammad Sajid Hussain, Qasim Raza, Muhammad Omer Aamir, Nadia Murtaza, Sadia Naureen, Mehwish Razzaq
Format: article
Langue:EN
Publié: Army Medical College Rawalpindi 2021
Sujets:
R
Accès en ligne:https://doi.org/10.51253/pafmj.v71i1.2489
https://doaj.org/article/200da42cfcd8473eb242201c91a2c6b5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!